Azienda Ospedaliera Universitaria Di Cagliari

At Azienda Ospedaliera Universitaria Di Cagliari, the main focus in oncology is advanced colorectal cancer, with a strong emphasis on patients carrying the KRAS G12C mutation. These studies are designed to assess whether new treatment combinations can improve disease control and offer better options after standard therapy.

• Advanced colorectal cancer with KRAS G12C mutation
• Testing new treatment strategies for patients whose disease has progressed after first-line care
• Comparing targeted therapy combinations with standard chemotherapy

This research helps evaluate whether more precise cancer treatments can improve outcomes for people with difficult-to-treat neoplasms.

The site also conducts clinical research in respiratory tract diseases, especially severe asthma with an eosinophilic phenotype. These trials aim to better understand long-term safety and support more effective control of persistent asthma symptoms in patients already receiving standard care.

• Severe asthma with an eosinophilic phenotype
• Evaluating long-term safety of new add-on treatment options
• Improving management for patients with difficult-to-control asthma

Overall, the respiratory studies are focused on expanding treatment choices and improving the quality of life for people living with chronic asthma.